Gene · 4973
Papers4,129
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,129
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations. | Front Immunol | 2022 | 36248793 | PubTator, text mining | PubMed |
| Lipid Metabolism in Cartilage Development, Degeneration, and Regeneration. | Nutrients | 2022 | 36235637 | PubTator, text mining | PubMed |
| New Insights into Dietary Pterostilbene: Sources, Metabolism, and Health Promotion Effects. | Molecules | 2022 | 36234852 | PubTator, text mining | PubMed |
| Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism. | Int J Mol Sci | 2022 | 36232754 | PubTator, text mining | PubMed |
| Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell. | Int J Mol Sci | 2022 | 36232746 | PubTator, text mining | PubMed |
A Systematic Review on Attenuation of PCSK9 in Relation to Atherogenesis Biomarkers Associated with Natural Products or Plant Bioactive Compounds in In Vitro Studies: A Critique on the Quality and Imprecision of Studies. | Int J Environ Res Public Health | 2022 | 36232177 | PubTator, text mining | PubMed |
| High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth-Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen. | Cancers (Basel) | 2022 | 36230888 | PubTator, text mining | PubMed |
| Angiotensin II type 2 receptor prevents extracellular matrix accumulation in human peritoneal mesothelial cell by ameliorating lipid disorder via LOX-1 suppression. | Ren Fail | 2022 | 36226438 | PubTator, text mining | PubMed |
| Application of Cytochrome C-Related Genes in Prognosis and Treatment Prediction of Lung Adenocarcinoma. | Dis Markers | 2022 | 36225197 | PubTator, text mining | PubMed |
| Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases. | Oxid Med Cell Longev | 2022 | 36225176 | PubTator, text mining | PubMed |
| Identification of Survival-Related Genes in Acute Myeloid Leukemia (AML) Based on Cytogenetically Normal AML Samples Using Weighted Gene Coexpression Network Analysis. | Dis Markers | 2022 | 36212177 | PubTator, text mining | PubMed |
| Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis. | Front Cardiovasc Med | 2022 | 36211578 | PubTator, text mining | PubMed |
| The function of myeloid-derived suppressor cells in COVID-19 lymphopenia. | Int Immunopharmacol | 2022 | 36206651 | PubTator, text mining | PubMed |
| Lipid metabolic features of T cells in the Tumor Microenvironment. | Lipids Health Dis | 2022 | 36203151 | PubTator, text mining | PubMed |
| Arterial stiffness nomogram identification by cluster analysis: A new approach of vascular phenotype modeling. | J Clin Hypertens (Greenwich) | 2022 | 36196587 | PubTator, text mining | PubMed |
| Decreased Polymorphonuclear Myeloid-Derived Suppressor Cells and ROS Production Correlated Closely with Bronchopulmonary Dysplasia in Preterm Infants. | Oxid Med Cell Longev | 2022 | 36193058 | PubTator, text mining | PubMed |
| Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood. | Front Immunol | 2022 | 36189252 | PubTator, text mining | PubMed |
| Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease. | Clin Transl Immunology | 2022 | 36188122 | PubTator, text mining | PubMed |
| Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview. | Front Oncol | 2022 | 36185215 | PubTator, text mining | PubMed |
| Long-term osteogenic differentiation of human bone marrow stromal cells in simulated microgravity: novel proteins sighted. | Cell Mol Life Sci | 2022 | 36181557 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/papers?page=43